Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd-$

$DRAGARWQHospitalBSE

Dr Agarwals Eye Hospital Ltd-$ (DRAGARWQ) last traded at ₹5,356, a market capitalisation of ₹2,588 crore, on a P/E of 34.0. Over the past 52 weeks the stock has ranged between ₹4,231 and ₹6,392. Dr Agarwals Eye Hospital Ltd-$ last reported results for the quarter ended Jun 2026, with sales of ₹143 crore and net profit of ₹23 crore. Dr Agarwals Eye Hospital Ltd-$’s annual general meeting is scheduled for 9 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Dr Agarwals Eye Hospital Ltd-$ share price and key metrics

Current price
₹5,356
Market cap
₹2,588 cr
Stock P/E
34.0
Book value
₹717
ROE
25.2%
ROCE
17.4%
Dividend yield
0.13%
52w high / low
6392/4231

Metrics as of 25 Aug 2026. Not real time.

Dr Agarwals Eye Hospital Ltd-$ quarterly results

In the quarter ended Jun 2026, sales were ₹143 cr, up 22.2% from ₹117 cr a year earlier. Net profit was ₹23 cr, up 35.3% year on year.

Dr Agarwals Eye Hospital Ltd-$ consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales10295100117118116120143
Expenses72696880788286100
Operating profit3026323740343443
OPM %29%27%32%32%34%30%28%30%
Other income22011322
Interest44344223
Depreciation910101111121211
Profit before tax1914192326232131
Tax %26%26%14%26%25%26%24%24%
Net profit1410161719171623
EPS (₹)30.1122.1334.0236.7239.9835.7633.6048.38

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Dr Agarwals Eye Hospital Ltd-$ annual results

Dr Agarwals Eye Hospital Ltd-$ annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales140201268319397471497
Operating profit31597692120145151
OPM %22%29%28%29%30%31%30%
Net profit-1243746557076
EPS (₹)-3.0651.2878.5598.64116.28145.05157.72

TTM is the trailing twelve months to the most recent quarter.

Dr Agarwals Eye Hospital Ltd-$ growth and returns

Compounded Sales Growth
10 Years
13%
5 Years
27%
3 Years
21%
TTM
20%
Compounded Profit Growth
10 Years
35%
5 Years
120%
3 Years
24%
TTM
32%
Stock Price CAGR
10 Years
39%
5 Years
68%
3 Years
38%
1 Year
1%
Return on Equity
10 Years
28%
5 Years
31%
3 Years
29%
Last Year
25%

Dr Agarwals Eye Hospital Ltd-$ shareholding pattern

Promoters held 72.67% at Jun 2026, up from 71.90% at Jun 2025. FIIs 2.24% and DIIs 2.05%.

Dr Agarwals Eye Hospital Ltd-$ shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters71.90%71.90%71.90%71.90%72.67%72.67%72.67%72.67%
FIIs0.83%0.84%1.33%1.49%1.74%1.82%2.20%2.24%
DIIs0.96%1.04%1.95%2.31%2.36%2.36%2.12%2.05%
Public26.32%26.22%24.82%24.29%23.22%23.15%22.99%23.03%
No. of shareholders4,51015,11541,70435,97630,52825,44924,03622,954

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Dr Agarwals Eye Hospital Ltd-$’s AGM?

Dr Agarwals Eye Hospital Ltd-$’s annual general meeting is scheduled for 9 Sept 2026.

  • AGM32nd Annual General Meeting, including dividend approval and director remuneration revision

See the full results calendar for every Indian company reporting in the next 30 days.

Dr Agarwals Eye Hospital Ltd-$ corporate filings

  • Newspaper Advertisement published for the 32nd Annual General Meeting is submitted.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: The company has filed a copy of the newspaper advertisement regarding its 32nd Annual…

    Read the full analysis
  • The record date for the payment of final dividend for the financial year 2025-26 is submitted.Corp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Dr. Agarwal's Eye Hospital Limited has scheduled its 32nd Annual General Meeting for…

    Read the full analysis
  • Annual Report of Dr. Agarwal's Eye Hospital Limited for the financial year 2025-26 is submittedOtherslow impact
    Filing PDF

    Cruxal's analysis: Dr. Agarwal's Eye Hospital Limited has filed its Annual Report for the financial year…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual FundInsider Trading / SASTmedium impact
    Filing PDF

    Cruxal's analysis: Invesco Mutual Fund has disclosed an acquisition of shares in Dr. Agarwal's Healthcare…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Dr Agarwals Eye Hospital Ltd-$

Cruxal reads every Dr Agarwals Eye Hospital Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Dr Agarwals Eye Hospital Ltd-$ (DRAGARWQ) Results, Financials & Share Price | Cruxal